Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20200107)
Due Date
January 07, 2026
Grace Period Ends
July 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 7, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 7, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 3, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Dec 2, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 27, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 22, 2019 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 22, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 24, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 23, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| May 21, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 23, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 21, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 17, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 15, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 15, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 15, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 11, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 11, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 17, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 15, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 15, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 15, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 24, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 22, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 22, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 22, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 22, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 27, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 27, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 7, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 25, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 17, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 16, 2016 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Aug 16, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 9, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 24, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 24, 2016 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 24, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 17, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 17, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 16, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 16, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 16, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 14, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 29, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease
First Use Anywhere:
Apr 15, 2019
First Use in Commerce:
Apr 15, 2019
Classification
International Classes
005